Related Experiment Video
Updated: Jun 4, 2026
07:08
Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
Published on: March 6, 2018
Bisphenol A and children's health
1Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Current Opinion in Pediatrics
|February 5, 2011
Summary
Bisphenol A (BPA) exposure may impact child development, with studies suggesting links to hormonal changes and behavioral issues. More research is needed to confirm these associations in humans.
Area of Science:
- Environmental Health
- Endocrinology
- Pediatrics
Background:
- Bisphenol A (BPA) is a ubiquitous chemical with demonstrated adverse effects in animal studies, especially after early life exposure.
- Human exposure is widespread, yet epidemiological data on BPA's health impacts remain limited.
- This review focuses on the existing epidemiological literature concerning childhood health outcomes.
Purpose of the Study:
- To summarize the epidemiological evidence on Bisphenol A (BPA) and adverse health outcomes.
- To specifically highlight findings related to childhood health.
- To assess the need for further research and clinical guidance.
Main Methods:
- Literature review of epidemiological studies on Bisphenol A (BPA).
- Emphasis on studies investigating early life and childhood exposures.
- Synthesis of findings on hormonal and developmental effects.
Main Results:
- Correlations observed between urinary BPA levels and sex hormone concentrations in adults.
- Weak associations found between BPA and delayed breast development in girls.
- Prenatal BPA exposure linked to increased hyperactivity and aggression in young girls.
Conclusions:
- Further large prospective cohort studies are essential to validate animal study findings.
- Concerns regarding BPA's adverse effects are justified due to fetal and child vulnerability.
- Healthcare providers should promote primary prevention and advise patients on reducing BPA exposure.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...